Shujun Feng

Shujun Feng

Auto-generated profile, based on publicly available information

Shujun Feng

College of Engineering and Applied Sciences Nanjing University 210023 Nanjing China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2024 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
YWYanping Wang
Yanping Wang
SFShujun Feng
Shujun Feng
XWXuyuan Wang
Xuyuan Wang
CTChungui Tao
Chungui Tao
YLYuta Liu
Yuta Liu
YSYujun Song
Yujun Song
Zeolitic imidazolate framework-8 (ZIF-8) encapsulating enzymatically active biomolecules has emerged as a novel biocompatible nanozyme and offers significant implications for bioanalysis of various biomarkers towards early diagnosis of severe diseases such as cancers. However, the rapid, continuous and scalable synthesis of these nanozymes still remains challenging. In this work, we proposed a novel microfluidic approach for rapid and continuous synthesis of hemin@ZIF-8 nanozyme. By employing a distinctive combination of zigzag-shaped channel and spiral channel with sudden expansion structures, we have enhanced the mixing efficiency within the chip and achieved effective encapsulation of hemin in ZIF-8. The resulting hemin@ZIF-8 nanoparticles exhibit peroxidase-like activity and are capable of detecting free H2O2 with a limit of detection (LOD) as low as 45 nM, as well as H2O2 secreted by viable cells with a detection threshold of approximately 10 cells per mL. By leveraging this method, we achieved successful detection of cancer cells and effective screening of anticancer drugs that induce oxidative stress injury in cancer cells. This innovative microfluidic strategy offers a new avenue for synthesizing functional nanocomposites to facilitate the development of next-generation diagnostic tools for early disease detection and personalized medicine.

30 August 2024 in Science Advances
Verified
Journal Article
Open access
SFShujun Feng
Shujun Feng
YZYu Zhang
Yu Zhang
CHChunyuan Hou
Chunyuan Hou
YLYuta Liu
Yuta Liu
YGYanfeng Gao
Yanfeng Gao
JLJun Luo
Jun Luo
Despite the therapeutic benefits of insulin-pramlintide dual-hormone therapy in diabetes, its application potential has been limited due to a lack of efficient delivery routes. Here, we developed a temperature-responsive dual-hormone foam nanoengine (HormFoam) and combined it with a customized spraying device to further construct an in situ foam-generating system for improving the rectal bioavailability of dual-hormone therapy. To support rapid clinical translation, a continuous microfluidic preparation for HormFoam was proposed, including the power unit of perfluorocarbon nanodroplets and the pharmaceutical components Pluronic F127–functionalized liposomal insulin and pramlintide. We found that HormFoam could consistently generate foams to drive drugs forward after rectal administration, which enhanced intestinal distribution and mucosa absorption, leading to systemic codelivery of insulin-pramlintide. HormFoam reproduced the physiology of endocrine pancreas for glycemic control and induced body weight loss while reversing metabolic disorders in diabetic mice with good biosafety. Therefore, HormFoam represents a state-of-the-art dual-hormone regimen with the potential to address unmet needs in diabetes management.

16 October 2024 in Chemistry – A European Journal
Verified
Journal Article
Closed access
SFShujun Feng
Shujun Feng
YZYu Zhang
Yu Zhang
YWYanyi Wang
Yanyi Wang
YGYanfeng Gao
Yanfeng Gao
YSYujun Song
Yujun Song